Can an MRI replace a PET scan for bone marrow in prostate cancer?
NCT ID NCT07609225
First seen May 27, 2026 · Last updated Jun 16, 2026 · Updated 3 times
Summary
This study tests whether a special MRI scan (CSE-MRI) can measure active bone marrow as accurately as a PET scan (FLT PET) in men with metastatic castration-resistant prostate cancer. Fifteen participants will receive both scans on the same day to compare results. The goal is to see if the MRI can be a simpler, radiation-free alternative for planning treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.